Skip to main content

Table 3 Adverse reactions after convalescent plasma administration

From: Convalescent anti-SARS-CoV-2 plasma for the treatment of patients with COVID-19: a retrospective study RESCOVID-19

number of patients enrolled (CP-group) (n = 406)

adverse reactions (n, %)

overall

9

2.2

circulatory overload

4

1.0

allergic reaction

2

0.5

febrile reaction

3

0.7

  1. CP, convalescent plasma